ALERGIAS
AstraZeneca (United Kingdom)
Cambridge, Reino UnidoPublikationen in Zusammenarbeit mit Forschern von AstraZeneca (United Kingdom) (1)
2021
-
Real-world study in severe eosinophilic asthma patients refractory to anti-IL5 biological agents treated with benralizumab in Spain (ORBE study)
BMC Pulmonary Medicine, Vol. 21, Núm. 1